Jim Simons In Med Pharmaceuticals Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in In Med Pharmaceuticals Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 28,300 shares of INM stock, worth $7,358. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,300
Previous 38,900
27.25%
Holding current value
$7,358
Previous $16,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding INM
# of Institutions
19Shares Held
686KCall Options Held
0Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ362KShares$94,0494.44% of portfolio
-
Armistice Capital, LLC New York, NY267KShares$69,4110.0% of portfolio
-
Two Sigma Securities, LLC New York, NY15.4KShares$4,0090.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il12.7KShares$3,3080.0% of portfolio
-
Qube Research & Technologies LTD London, X0200Shares$520.0% of portfolio
About InMed Pharmaceuticals Inc.
- Ticker INM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 908,761
- Market Cap $236K
- Description
- InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...